☆ 4.6 Article

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly

CELLS (2022)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

High-risk pituitary adenomas and strategies for predicting response to treatment

George Kontogeorgos et al.

Summary: This article provides a detailed description of the morphological and immunohistochemical characteristics of high-risk pituitary adenomas, as well as the clinical features and treatment options. Predictive markers assessed by immunohistochemistry help clinicians design appropriate treatment strategies for high-risk adenomas.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

Joan Gil et al.

Summary: Acromegaly is a condition caused by excessive growth hormone production due to a pituitary tumor. This study examines the relationship between epithelial-mesenchymal transition (EMT) and resistance to somatostatin receptor ligands (SRLs) in GH-producing tumors. The findings suggest that EMT-related gene expression patterns are heterogeneous, which may explain the varying responses to SRLs.

BIOMEDICINES (2022)

Add to Collection

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Pituitary Tumors

Sylvia L. Asa et al.

Summary: This review summarizes the changes in the 5th Edition of the WHO Classification of Endocrine and Neuroendocrine Tumors related to the pituitary gland, including the classification of pituitary lobe tumors and the detailed subtyping based on tumor cell lineage, cell type, and characteristics.

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Ghrelin Based Therapy of Metabolic Diseases

Yuan Liang et al.

Summary: Ghrelin-GHSR signaling plays a critical role in energy homeostasis, and therapeutic strategies targeting this system for metabolic disorders involve various approaches such as neutralization of ghrelin, antagonism of ghrelin receptor, and inhibition of ghrelin O-acyltransferase. Compounds targeting this system have shown promising efficacy in animals and in vitro studies, but further clinical trials are needed to validate their efficacy in humans.

CURRENT MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Endocrinology & Metabolism

Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

Joan Gil et al.

Summary: Only two out of 21 molecular markers studied could predict enhanced SRLs response after surgical debulking in large GH-producing tumors. Tumors with improved response to SRLs post-surgery showed lower Ki-67 levels (MKI67, FC = 0.17 and P = .008) and higher levels of RAR-related orphan receptor C (RORC) (FC = 3.1 and P < .001).

CLINICAL ENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly

Amy A. Swanson et al.

Summary: This study analyzed histologic subtypes of growth hormone-producing pituitary adenomas in acromegaly patients and found that histologic subtype did not predict surgical outcome, while absence of invasion and lower pre-operative IGF-1 index were significantly associated with post-surgical remission.

PITUITARY (2021)

Add to Collection

Article Endocrinology & Metabolism

The Complex World of Regulation o f Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It

Jesus Devesa

Summary: In recent years, the classic concept of pituitary GH regulation by somatostatin and GHRH has changed with the discovery of peripheral hormones like ghrelin, nesfatins, and klotho. These hormones play important roles in energy and mineral homeostasis regulation, impacting the synthesis and secretion of pituitary GH.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Invasive and Noninvasive Nonfunctioning Gonadotroph Pituitary Tumors Differ in DNA Methylation Level of LINE-1 Repetitive Elements

Natalia Rusetska et al.

Summary: The study found that hypomethylation of LINE-1 in pituitary tumors is associated with invasive growth and influences the transcriptional activity of transposable elements. Tumors with invasive growth had significantly lower levels of methylation compared to noninvasive ones, and methylation of LINE-1 correlated with overall DNA methylation. Treating gonadotroph cells with a DNA methyltransferase inhibitor led to increased expression of LINE-1 open reading frames, with more pronounced effects in certain cell types. Immunoreactivity against LINE-1 in tumors was higher compared to normal tissue, but no difference was observed between invasive and noninvasive tumors.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Endocrinology & Metabolism

Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

Joan Gil et al.

Summary: Epithelial-mesenchymal transition is a dynamic process that plays essential roles in both physiological and pathological processes, particularly in the growth and invasion of pituitary tumors. Studies have shown the association of EMT with resistance to somatostatin receptor ligands in the treatment of acromegaly.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Book Review Biology

Interactive web-based data visualization with R, plotly, and shiny

Ran Li et al.

BIOMETRICS (2021)

Add to Collection

Review Endocrinology & Metabolism

Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose

Mirella Hage et al.

Summary: Recent studies have focused on somatotroph pituitary adenomas in acromegaly patients showing a paradoxical GH response during OGTT, which has been linked to the ectopic expression of GIP receptor in adenoma cells. These adenomas are negative for activating GNAS gene mutations and have unique cytogenetic and DNA methylation profiles. Patients with paradoxical GH response pattern have higher IGF-1 levels and smaller adenomas, often densely granulated, and may respond better to somatostatin receptor ligands. Targeted therapy against GIP receptor on these adenomas could be a new treatment approach for these patients.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

Add to Collection

Article Clinical Neurology

Expression of Transforming Growth Factor β1, Smad3, and Phospho-Smad3 in Somatotropinomas and Their Relationship to Tumor Behavior

Zhenye Li et al.

Summary: The study found that low expression of p-Smad3 is correlated with the invasion of somatotropinomas. TGF-beta 1 and p-Smad3 scores were associated with invasion.

WORLD NEUROSURGERY (2021)

Add to Collection

Article Oncology

Pangenomic Classification of Pituitary Neuroendocrine Tumors

Mario Neou et al.

CANCER CELL (2020)

Add to Collection

Article Endocrinology & Metabolism

The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes

Daniela Regazzo et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)

Add to Collection

Article Oncology

Molecular profiling for acromegaly treatment: a validation study

Manel Puig-Domingo et al.

ENDOCRINE-RELATED CANCER (2020)

Add to Collection

Article Endocrinology & Metabolism

Diagnostics and treatment of acromegaly - updated recommendations of the Polish Society of Endocrinology

Marek Bolanowski et al.

ENDOKRYNOLOGIA POLSKA (2019)

Add to Collection

Article Multidisciplinary Sciences

Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles

Maria Caroline Alves Coelho et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Medicine, General & Internal

The Clinicopathological Spectrum of Acromegaly

Amit Akirov et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection

Article Endocrinology & Metabolism

Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas

Mirella Hage et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Add to Collection

Article Cell Biology

Common and diverse elements of ion channels and receptors underlying electrical activity in endocrine pituitary cells

Patrick A. Fletcher et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Add to Collection

Article Biology

Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly

G. A. Mendes et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)

Add to Collection

Review Endocrinology & Metabolism

Ca2+ Channels in Anterior Pituitary Somatotrophs: A Therapeutic Perspective

Itzhak Nussinovitch

ENDOCRINOLOGY (2018)

Add to Collection

Article Oncology

Pituitary acromegaly: not one disease

Sylvia L. Asa et al.

ENDOCRINE-RELATED CANCER (2017)

Add to Collection

Article Endocrinology & Metabolism

The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp- somatotropinomas

D. Regazzo et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)

Add to Collection

Article Endocrinology & Metabolism

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

Donato Iacovazzo et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Add to Collection

Article Endocrinology & Metabolism

Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly

Federico Gatto et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Add to Collection

Article Endocrinology & Metabolism

Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas

N. Chauvet et al.

JOURNAL OF NEUROENDOCRINOLOGY (2016)

Add to Collection

Article Medicine, Research & Experimental

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

Cuiqi Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Add to Collection

Article Cell Biology

Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors

Katja Kiseljak-Vassiliades et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)

Add to Collection

Article Biochemical Research Methods

HISAT: a fast spliced aligner with low memory requirements

Daehwan Kim et al.

NATURE METHODS (2015)

Add to Collection

Article Endocrinology & Metabolism

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis

Z. A. Efstathiadou et al.

PITUITARY (2015)

Add to Collection

Article Biochemical Research Methods

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Yang Liao et al.

BIOINFORMATICS (2014)

Add to Collection

Article Cell Biology

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

E. Vitali et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Marked Cortisol Production by Intracrine ACTH in GIP-Treated Cultured Adrenal Cells in Which the GIP Receptor Was Exogenously Introduced

Hiroko Fujii et al.

PLOS ONE (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Add to Collection

Article Biochemical Research Methods

Pathview: an R/Bioconductor package for pathway-based data integration and visualization

Weijun Luo et al.

BIOINFORMATICS (2013)

Add to Collection

Article Endocrinology & Metabolism

β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly

Federico Gatto et al.

ENDOCRINOLOGY (2013)

Add to Collection

Article Endocrinology & Metabolism

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas

Sarah Larkin et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)

Add to Collection

Article Endocrinology & Metabolism

Gipr Is Essential for Adrenocortical Steroidogenesis, However, Corticosterone Deficiency Does Not Mediate the Favorable Metabolic Phenotype of Gipr-/- Mice

Holly E. Bates et al.

DIABETES (2012)

Add to Collection

Article Endocrinology & Metabolism

The Glucose-Dependent Insulinotropic Polypeptide Receptor is Overexpressed Amongst GNAS1 Mutation-Negative Somatotropinomas and Drives Growth Hormone (GH)-Promoter Activity in GH3 Cells

G. Occhi et al.

JOURNAL OF NEUROENDOCRINOLOGY (2011)

Add to Collection

Review Medicine, General & Internal

Medical progress: Acromegaly

Shlomo Melmed

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Add to Collection

Article Endocrinology & Metabolism

Double adenomas of the pituitary: Transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation

RA Jastania et al.

ENDOCRINE PATHOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.